Unitree G1 Humanoid Robot Completes First Live Minimally Invasive Surgery

A University of California San Diego team has reported that a Unitree G1 humanoid robot carried out standard laparoscopic cholecystectomy on two live pigs. The second procedure lasted 32 minutes. The work appears in a recent Nature paper and marks the first recorded instance of a humanoid platform completing an entire minimally invasive operation on living tissue.

The surgeons used off-the-shelf laparoscopic tools mounted on the G1. The robot followed routine surgical sequences without custom hardware. Researchers noted that the robot required repeated manual corrections for positioning and grasping. The platform also failed current operating-room sterility requirements because its surface design and joint gaps cannot be fully sterilized with standard protocols.

What the experiment actually demonstrated

The procedures focused on gallbladder removal, a common laparoscopic task. In the first case the team recorded multiple pauses for recalibration. In the second case the robot completed the steps in 32 minutes. Both pigs survived the operations according to the paper. No human patients were involved.

The team chose the G1 partly because its 1.32-meter height and standard gripper reach align with typical operating-table geometry. Cost estimates in the paper place the complete system at roughly one-twentieth the price of a da Vinci Xi platform. The authors did not publish exact purchase figures.

Why this result creates pressure on existing surgical-robot makers

Current market leaders sell systems priced above two million dollars per unit plus annual service contracts. Hospitals in smaller regions rarely adopt them. A platform that can be adapted from an existing humanoid at far lower cost would change purchasing calculations for mid-tier medical centers.

The Nature paper does not claim the G1 meets regulatory standards for human use. It simply shows that the kinematic structure of a general-purpose humanoid can execute the required motions. This shifts the discussion from hardware capability to software reliability and sterilization engineering.

Remaining technical gaps

The robot needed human intervention to adjust arm angles and re-grasp instruments during both procedures. No vision system on the G1 automatically compensated for tissue deformation. Sterility remains unsolved because the robot’s exposed joints and plastic covers cannot withstand autoclave temperatures or chemical soaks without damage.

The authors list three next engineering targets: sealed joint covers, integrated sterile draping interfaces, and closed-loop visual servoing that reduces the need for manual corrections. None of these are currently available on the commercial G1.

What regulators and hospitals will watch next

The Food and Drug Administration has not issued guidance specific to humanoid surgical platforms. Any future submission will need to demonstrate both task performance and infection-control compliance. Hospitals will also track whether Unitree or third-party integrators release a version with sealed, autoclavable components.

Over the next three to six months the clearest signals will come from peer-reviewed follow-up studies on additional procedures and any announcement of a sterility-certified G1 variant. Absence of those milestones will keep the current result in the experimental category.